Is Upadacitinib a hormonal drug?

Upadacitinib is not a hormonal drug, but a selective Janus kinase inhibitor. Its main mechanism of action is to regulate abnormal immune responses in the body by inhibiting the JAK-STAT signaling pathway, thereby achieving the effect of treating autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis. Although it has anti-inflammatory and immunomodulatory effects, it does not contain steroid hormones and is therefore not a "hormone drug" in the traditional sense.

Unlike common glucocorticoid drugs (such as prednisone, dexamethasone), upadatinib does not act by activating hormone receptors in the body, and does not have the extensive metabolic effects common with hormonal drugs. Hormone drugs often control the disease quickly by regulating the systemic inflammatory response and suppressing the immune system, but they can also easily cause side effects such as water and sodium retention, osteoporosis, elevated blood sugar, and weight gain. As a targeted small molecule drug, upadatinib has a more precise effect, relatively controllable side effects, and is suitable for long-term maintenance treatment.

In clinical treatment, upadatinib is often used as a long-term alternative to hormone drugs to reduce the use of glucocorticoids and avoid their side effects. Some patients may be combined with hormonal drugs in the early stages of the disease or during acute attacks, but as the condition stabilizes, doctors usually gradually stop using steroids and only retain upadatinib as a maintenance treatment drug, which also reflects its more advanced status in modern immunotherapy.

In general, although upadatinib has anti-inflammatory and immunomodulatory effects, it is not a hormonal drug and does not contain any hormonal ingredients. Compared with traditional hormone drugs, its mechanism of action is more targeted and its long-term safety is higher. If patients have questions about the type of drug, they should clarify the nature of the drug under the guidance of a doctor to arrange a reasonable treatment plan and reduce unnecessary worries.

Reference materials:https://www.rinvoq.com/